Method of producing a polypeptide or virus of interest in a continuous cell culture
View Patent ↗Described herein is a chemostat-like continuous cell culture system that combines certain advantages of perfusion open systems and chemostat open systems to improve the culturing of mammalian cells, e.g., genetically modified cells, particularly in serum-free or chemically-defined media. The continuous culture system described herein involves culturing mammalian cells in a continuous cell culture system, which comprises a cell retention device, wherein the cell culture system has a dilution rate (D) of less than about 2 d −1 , and a cell density of less than about 2×10 7 cell/mL. Also described herein is a method for producing a polypeptide and/or virus of interest in a continuous cell culture, the method comprising culturing mammalian cells expressing the polypeptide and/or virus of interest in a continuous cell culture system, which comprises a cell retention device, wherein the cell culture system has a dilution rate (D) of less than about 2 d −1 , and a cell density of less than about 2×10 7 cell/mL; and recovering the polypeptide and/or virus of interest from medium of the cell culture system.
1. A method for producing a disintegrin-like and metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13) protein in a continuous cell culture, said method comprising
(a) culturing mammalian cells genetically modified to express an ADAMTS13 protein in a continuous cell culture system, wherein said cell culture system has a dilution rate (D) of less than 0.6 d −1 , a ratio of the dilution rate to a specific growth rate (D/μ) of from 1.2 to 5, and a cell density of less than 2×10 7 cell/mL; and
(b) recovering said ADAMTS13 protein from medium removed from said cell culture system.
2. The method of claim 1 , wherein said culture system further comprises a cell retention device that produces a cell retention rate of less than 90%.
3. The method of claim 1 , wherein said cell density is less than 6×10 6 cell/mL.
4. The method of claim 1 , wherein said cell culture system has a specific growth rate of between 0.15 d −1 and 0.3 d −1 .
5. The method of claim 1 , wherein said cells are cultured in said cell culture system for more than 20 days.
6. The method of claim 1 , wherein said cells are cultured in said cell culture system for more than 40 days.
7. The method of claim 1 , wherein said cells are cultured in said cell culture system for more than 50 days.
8. The method of claim 2 , wherein said cell retention device comprises a macroporous microcarrier.
9. The method of claim 1 , wherein said cells are cultured in a serum-free medium.
10. The method of claim 1 , wherein said cells are cultured in at least 250 L of medium.
11. The method of claim 1 , wherein said cells are non-anchorage dependent cells.
12. The method of claim 1 , further comprising, before the culturing step, pre-culturing the cells in suspension.
13. The method of claim 1 , wherein said cells are CHO cells.
14. The method of claim 1 , wherein said cell density is from 1×10 6 to 2×10 6 cells/mL.
15. The method of claim 14 , wherein said cells are CHO cells.
16. The method of claim 15 , wherein said cell culture system has a cell retention rate of from 50% to 90%.
17. The method of claim 15 , wherein said cell culture system has a specific growth rate of between 0.15 d −1 and 0.3 d −1 .
18. The method of claim 16 , wherein said cell culture system has a specific growth rate of between 0.15 d −1 and 0.3 d −1 .
19. The method of claim 1 , wherein said cell culture system has a cell retention rate of from 50% to 90%.
20. The method of claim 19 , wherein said cells are CHO cells.
21. The method of claim 4 , wherein said cells are CHO cells.